These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


198 related items for PubMed ID: 7963563

  • 1. Tepoxalin, a novel immunosuppressive agent with a different mechanism of action from cyclosporin A.
    Zhou L, Ritchie D, Wang EY, Barbone AG, Argentieri D, Lau CY.
    J Immunol; 1994 Dec 01; 153(11):5026-37. PubMed ID: 7963563
    [Abstract] [Full Text] [Related]

  • 2. Distinct mechanisms of suppression of murine T cell activation by the related macrolides FK-506 and rapamycin.
    Dumont FJ, Staruch MJ, Koprak SL, Melino MR, Sigal NH.
    J Immunol; 1990 Jan 01; 144(1):251-8. PubMed ID: 1688572
    [Abstract] [Full Text] [Related]

  • 3. The immunosuppressive macrolides FK-506 and rapamycin act as reciprocal antagonists in murine T cells.
    Dumont FJ, Melino MR, Staruch MJ, Koprak SL, Fischer PA, Sigal NH.
    J Immunol; 1990 Feb 15; 144(4):1418-24. PubMed ID: 1689353
    [Abstract] [Full Text] [Related]

  • 4. Evidence for IL-2 independent proliferation in human T cells.
    Laing TJ, Weiss A.
    J Immunol; 1988 Feb 15; 140(4):1056-62. PubMed ID: 2830333
    [Abstract] [Full Text] [Related]

  • 5. The Chinese herbal remedy, T2, inhibits mitogen-induced cytokine gene transcription by T cells, but not initial signal transduction.
    Tao X, Davis LS, Hashimoto K, Lipsky PE.
    J Pharmacol Exp Ther; 1996 Jan 15; 276(1):316-25. PubMed ID: 8558449
    [Abstract] [Full Text] [Related]

  • 6. Cyclosporin A inhibits the early phase of NF-kappaB/RelA activation induced by CD28 costimulatory signaling to reduce the IL-2 expression in human peripheral T cells.
    Nishiyama S, Manabe N, Kubota Y, Ohnishi H, Kitanaka A, Tokuda M, Taminato T, Ishida T, Takahara J, Tanaka T.
    Int Immunopharmacol; 2005 Apr 15; 5(4):699-710. PubMed ID: 15710339
    [Abstract] [Full Text] [Related]

  • 7. Cyclosporin A inhibits initiation but not progression of human T cell proliferation triggered by phorbol esters and calcium ionophores.
    Kumagai N, Benedict SH, Mills GB, Gelfand EW.
    J Immunol; 1988 Dec 01; 141(11):3747-52. PubMed ID: 3263432
    [Abstract] [Full Text] [Related]

  • 8. A humanised therapeutic CD4 mAb inhibits TCR-induced IL-2, IL-4, and IL-10 secretion and expression of CD25, CD40L, and CD69.
    Woods M, Guy R, Waldmann H, Glennie M, Alexander DR.
    Cell Immunol; 1998 May 01; 185(2):101-13. PubMed ID: 9636688
    [Abstract] [Full Text] [Related]

  • 9. Suppression of NF kappa B activation and NF kappa B-dependent gene expression by tepoxalin, a dual inhibitor of cyclooxygenase and 5-lipoxygenase.
    Kazmi SM, Plante RK, Visconti V, Taylor GR, Zhou L, Lau CY.
    J Cell Biochem; 1995 Feb 01; 57(2):299-310. PubMed ID: 7759567
    [Abstract] [Full Text] [Related]

  • 10. Transforming growth factor beta 1 inhibits interleukin-1-induced but enhances ionomycin-induced interferon-gamma production in a T cell lymphoma: comparison with the effects of rapamycin.
    Dumont FJ, Kastner CA.
    J Cell Physiol; 1994 Jul 01; 160(1):141-53. PubMed ID: 8021294
    [Abstract] [Full Text] [Related]

  • 11. Inhibition of human T cell activation by novel Src kinase inhibitors is dependent upon the complexity of the signal delivered to the cell.
    Rapecki S, Allen R.
    J Pharmacol Exp Ther; 2002 Dec 01; 303(3):1325-33. PubMed ID: 12438558
    [Abstract] [Full Text] [Related]

  • 12. FTY720, a novel immunosuppressant, induces sequestration of circulating mature lymphocytes by acceleration of lymphocyte homing in rats. II. FTY720 prolongs skin allograft survival by decreasing T cell infiltration into grafts but not cytokine production in vivo.
    Yanagawa Y, Sugahara K, Kataoka H, Kawaguchi T, Masubuchi Y, Chiba K.
    J Immunol; 1998 Jun 01; 160(11):5493-9. PubMed ID: 9605152
    [Abstract] [Full Text] [Related]

  • 13. The immunosuppressant FK506 selectively inhibits expression of early T cell activation genes.
    Tocci MJ, Matkovich DA, Collier KA, Kwok P, Dumont F, Lin S, Degudicibus S, Siekierka JJ, Chin J, Hutchinson NI.
    J Immunol; 1989 Jul 15; 143(2):718-26. PubMed ID: 2472451
    [Abstract] [Full Text] [Related]

  • 14. Novel mechanism for inhibition of human T cells by glucocorticoids. Glucocorticoids inhibit signal transduction through IL-2 receptor.
    Paliogianni F, Ahuja SS, Balow JP, Balow JE, Boumpas DT.
    J Immunol; 1993 Oct 15; 151(8):4081-9. PubMed ID: 8409387
    [Abstract] [Full Text] [Related]

  • 15. Inhibition of murine T cell activation by cholera toxin B subunit is not mediated through the phosphatidylinositol second messenger system.
    Woogen SD, Turo K, Dieleman LA, Beagley KW, Elson CO.
    J Immunol; 1993 Apr 15; 150(8 Pt 1):3274-83. PubMed ID: 8468469
    [Abstract] [Full Text] [Related]

  • 16. Vomitoxin-mediated IL-2, IL-4, and IL-5 superinduction in murine CD4+ T cells stimulated with phorbol ester calcium ionophore: relation to kinetics of proliferation.
    Ouyang YL, Azcona-Olivera JI, Murtha J, Pestka JJ.
    Toxicol Appl Pharmacol; 1996 Jun 15; 138(2):324-34. PubMed ID: 8658534
    [Abstract] [Full Text] [Related]

  • 17. Deficient CD4+ T cell proliferation in the class 1 MHC-restricted 2C TCR-transgenic mouse.
    Chen FL, Kung JT.
    J Immunol; 1996 Mar 15; 156(6):2036-44. PubMed ID: 8690890
    [Abstract] [Full Text] [Related]

  • 18. Novel immunosuppressive agent, FK506. In vitro effects on the cloned T cell activation.
    Sawada S, Suzuki G, Kawase Y, Takaku F.
    J Immunol; 1987 Sep 15; 139(6):1797-803. PubMed ID: 2442255
    [Abstract] [Full Text] [Related]

  • 19. Curcumin inhibits mitogen stimulated lymphocyte proliferation, NFkappaB activation, and IL-2 signaling.
    Ranjan D, Chen C, Johnston TD, Jeon H, Nagabhushan M.
    J Surg Res; 2004 Oct 15; 121(2):171-7. PubMed ID: 15501456
    [Abstract] [Full Text] [Related]

  • 20. Differential effects of the immunosuppressants cyclosporin A, FK506 and KM2210 on cytokine gene expression.
    Han CW, Imamura M, Hashino S, Zhu X, Tanaka J, Imai K, Matsudaira T, Asano S.
    Bone Marrow Transplant; 1995 May 15; 15(5):733-9. PubMed ID: 7545487
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 10.